Boehringer Ingelheim pledges EUR 11 billion to R&D
11 November 2015 | By Victoria White
Of the total investment, EUR 5 billion will go to preclinical R&D with EUR 1.5 billion thereof planned for collaborations with external partners...
List view / Grid view
News
GeneOne Life Science and WRAIR to develop MERS vaccine
11 November 2015 | By Victoria White
Earlier this year, GLS-5300 induced 100% protection from a live MERS virus challenge in a preclinical animal study...
Studies justify mode of delivery and dosing regimen for Anisina
11 November 2015 | By Victoria White
Preclinical studies confirm the efficacy of Anisina when delivered using a clinically relevant formulation, mode of administration and dosing regimen...
Scientists help launch human dark proteome initiative
10 November 2015 | By Victoria White
The initiative aims to accelerate research into biology's "invisible mass" to provide novel insights into cell function and a new frontier in drug discovery...
Scientists use dead C. sporogenes bacteria to kill cancer cells
10 November 2015 | By Victoria White
In a 72-hour experiment, the inactive bacteria were able to reduce the growth of colon tumour cells by 74%...
E12-7Fc-M3 demonstrates efficacy as treatment for cocaine overdose
10 November 2015 | By Victoria White
E12-7Fc-M3 not only demonstrated a significantly improved efficiency against cocaine, but also had a considerably prolonged biological half-life in animal models...
Cholesterol-lowering vaccine shows promise in preclinical studies
10 November 2015 | By Victoria White
Scientists from the University of New Mexico and NIH have created a cholesterol-lowering vaccine that leads to reductions in LDL cholesterol in mice and macaques...
Boehringer Ingelheim announces IBD research collaborations
10 November 2015 | By Victoria White
The collaborations aim to identify and validate potential new therapeutic targets as well as identify biomarkers...
Pharnext’s PXT-864 shows promise in Parkinson’s disease
10 November 2015 | By Victoria White
In preclinical studies, researchers showed that PXT-864, a combination of baclofen and acamprosate, improved multiple endpoints associated with the development and progression of Parkinson's disease...
Sanofi Pasteur reveals universal flu vaccine research
10 November 2015 | By Victoria White
Sanofi Pasteur's experimental vaccine is a novel synthetic vaccine generated from key genetic sequences of many flu viruses...
Scientists discover genetic cause and mechanism of noise-induced hearing loss
6 November 2015 | By Victoria White
The absence of pejvakin appears to be responsible for noise-induced hearing loss, one of the most common causes of deafness...
Global and USA Biosimilar Market: Updates from Hospira, Sandoz, Merck, Teva, Boehringer Ingelheim
6 November 2015 | By SMi
Leading organizations in the Biosimilars Development sector will meet at Biosimilars and Biobetters USA 2015 – the must-attend premier industry event which will take place in Iselin this November...
Possible solution for Alzheimer’s immunotherapy side effect
6 November 2015 | By Victoria White
Scientists have discovered that small changes in anti-amyloid antibodies preserves the immunotherapeutic activity without the inflammatory side effects...
Scientists identify compound that could reverse cataracts
6 November 2015 | By Victoria White
Eye drops made with the compound partially restored transparency to mouse lenses affected by cataracts...
National MS Society invests $21m in 78 new research projects
6 November 2015 | By
This financial commitment is part of a projected investment of over $53 million in 2015 alone to support more than 380 new and ongoing studies around the world.